Emerging Markets Programme

The Emerging Markets programme was established to meet the needs of both companies and regulatory agencies for comparative data and information on the evolving regulatory environment in the emerging markets at the country and regional level. This programme focuses on 15 countries, including the biggest and fastest growing economies and the most prominent and promising emerging markets.

 Mission

• Build trust between stakeholders as the key to facilitate change to enhance predictability, transparency, timeliness and quality through various forums
• Describe best practices amongst stakeholders through science-based insight and recommendations to facilitate good regulatory practices
• Facilitate patients’ access to medicines through dialogue, workshops and research

 Activities

• Benchmarking: Benchmarking time taken to approve medicines and analysing influences of submission and approval time
• Focus Studies: Research studies focusing on specific areas of interest within the local and regional regulatory environments
• Industry Discussion Meetings: Peer-to-peer interactions and detailed discussions on the outcome of benchmarking and focus studies
• Regulators Forums: A platform for discussion among regulatory agencies to facilitate sharing views and approaches to changes in the regulations of new medicines
• Workshops: Interactive meetings bringing together regulators and industry representatives from emerging and developed markets to develop and improve good regulatory practices